Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,284,076
-$1,284,829 QoQ
Shares Held
8,836
-50.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#134
of 419 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. KRYS ranks #26 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in KRYS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,284,076 | 8,836 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,568,905 | 17,687 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,983,032 | 24,268 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,114,999 | 34,640 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,765,050 | 34,665 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,356,228 | 24,161 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,261,308 | 27,201 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,344,255 | 45,840 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,676,152 | 41,800 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,495,590 | 53,367 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,423,645 | 84,021 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,329,496 | 71,806 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,243,684 | 53,183 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,925,611 | 61,524 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,881,932 | 61,625 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,642,243 | 52,256 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,179,386 | 33,192 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,993,198 | 60,012 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,272,885 | 32,493 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,214,091 | 23,254 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,520,616 | 22,362 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,999,804 | 25,958 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $257,580 | 4,293 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $560,726 | 13,025 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $319,969 | 7,725 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||